Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas - With special regard to high-grade tumors

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 4, 2014, Pages 481-490

  Cornelius, J F ^a   Slotty, P J ^a   Kamp, M A ^a   Schneiderhan, T M ^a   Steiger, H J ^a   El Khatib, M ^a,b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

5 ALA; Aminolevulinic acid; Fluorescence guided surgery; High grade; Meningioma; Skull base

Indexed keywords

AMINOLEVULINIC ACID; CONTRAST MEDIUM; FLUORESCENT DYE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER TISSUE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLUORESCENCE GUIDED SURGERY; FLUORESCENCE IMAGING; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL DECISION MAKING; MENINGIOMA; MIDDLE AGED; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURGEON; VERY ELDERLY; WORLD HEALTH ORGANIZATION; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; DIAGNOSTIC USE; FLUORESCENCE MICROSCOPY; MENINGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CONTRAST MEDIA; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM GRADING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED;

EID: 84918802201     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2014.07.008     Document Type: Article

References (41)

1. Al-Mefty O., Kadri P.A., Pravdenkova S., Sawyer J.R., Stangeby C., Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 2004, 101:210-218.
2. Bruna J., Brell M., Ferrer I., Gimenez-Bonafe P., Tortosa A. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathol: Off J Jpn Soc Neuropathol 2007, 27:114-120.
3. Coluccia D., Fandino J., Fujioka M., Cordovi S., Muroi C., Landolt H. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir 2010, 152:1711-1719.
4. Cornelius J.F., Slotty P.J. Letters to the editor: meningioma surgery in the era of 5-aminolevulinic acid fluorescence-guided surgery. J Neurosurg 2014, [published online July 25].
5. Cornelius J.F., Slotty P.J., El Khatib M., Giannakis A., Senger B., Steiger H.J. Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells. Photodiag Photodyn Ther 2014, 11:1-6.
6. Cornelius J.F., Slotty P.J., Steiger H.J., Hanggi D., Polivka M., George B. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases. Acta Neurochir 2013, 155:407-413.
7. Cornelius J.F., Slotty P.J., Stoffels G., Galldiks N., Langen K.J., Steiger H.J. 5-Aminolevulinic Acid and (18)F-FET-PET as metabolic imaging tools for surgery of a recurrent skull base meningioma. J Neurol Surg Part B: Skull Base 2013, 74:211-216.
8. Della Puppa A., De Pellegrin S., d'Avella E., Gioffre G., Rossetto M., Gerardi A., et al. 5-Aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature. Acta Neurochir 2013, 155:965-972. [discussion 972].
9. Della Puppa A., Rustemi O., Gioffre G., Troncon I., Lombardi G., Rolma G., et al. Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery. J Neurosurg 2014, 120:840-845.
10. Ding D., Starke R.M., Hantzmon J., Yen C.P., Williams B.J., Sheehan J.P. The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas. Neurosurg Focus 2013, 35:E16.
11. Durand A., Labrousse F., Jouvet A., Bauchet L., Kalamarides M., Menei P., et al. WHO grade II and III meningiomas: a study of prognostic factors. J Neuro-oncol 2009, 95:367-375.
12. El-Khatib M., El Majdoub F., Hoevels M., Kocher M., Muller R.P., Steiger H.J., et al. Stereotactic LINAC, radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas. Acta Neurochir 2011, 153:1761-1767.
13. Ewelt C., Floeth F.W., Felsberg J., Steiger H.J., Sabel M., Langen K.J., et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 2011, 113:541-547.
14. Feigl G.C., Ritz R., Moraes M., Klein J., Ramina K., Gharabaghi A., et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 2010, 113:352-357.
15. Hefti M. Comment concerning: intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir 10.1007/s00701-010-0708-4. Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment. Acta Neurochir 2011, 153:959-960.
16. Hefti M., Mehdorn H.M., Albert I., Dorner L. Fluorescence-guided surgery for malignant glioma: a review on amino-levulinic acid induced protoporphyrin IX photodynamic diagnostic in brain tumors. Curr Med Imag Rev 2010, 6:1-5.
17. Jaaskelainen J.E. Role of intraoperative neurophysiological monitoring during fluorescence-guided resection surgery: aiming at seemingly complete resection of diffuse gliomas under 5-ALA guidance - is it safe?. Acta Neurochir 2013, 155:2215-2216.
18. Johnson W.D., Loredo L.N., Slater J.D. Surgery and radiotherapy: complementary tools in the management of benign intracranial tumors. Neurosurg Focus 2008, 24:E2.
19. Kajimoto Y., Kuroiwa T., Miyatake S., Ichioka T., Miyashita M., Tanaka H., et al. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. J Neurosurg 2007, 106:1070-1074.
20. Kostron H. Photodynamic diagnosis and therapy and the brain. Methods Mol Biol 2010, 635:261-280.
21. Kostron H., Daxenbichler G., Maier H. Steroid receptors and atypical histology as prognostic parameters in meningioma. Wiener klinische Wochenschrift 1990, 102:525-528.
22. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97-109.
23. Mirimanoff R.O., Dosoretz D.E., Linggood R.M., Ojemann R.G., Martuza R.L. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985, 62:18-24.
24. Monleon D., Morales J.M., Gonzalez-Segura A., Gonzalez-Darder J.M., Gil-Benso R., Cerda-Nicolas M., et al. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res 2010, 70:8426-8434.
25. Morofuji Y., Matsuo T., Hayashi Y., Suyama K., Nagata I. Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery 2008, 62:102-103. [discussion 103-104].
26. Pastor J., Vega-Zelaya L., Pulido P., Garnes-Camarena O., Abreu A., Sola R.G. Role of intraoperative neurophysiological monitoring during fluorescence-guided resection surgery. Acta Neurochir 2013, 155:2201-2213.
27. Peyre M., Clermont-Taranchon E., Stemmer-Rachamimov A., Kalamarides M. Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma. Brain Pathol 2013, 23:371-377.
28. Roberts D.W., Valdes P.A., Harris B.T., Fontaine K.M., Hartov A., Fan X., et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 2011, 114:595-603.
29. Santacroce A., Walier M., Regis J., Liscak R., Motti E., Lindquist C., et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 2012, 70:32-39. [discussion 39].
30. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957, 20:22-39.
31. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., Reulen H.J., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7:392-401.
32. Valdes P.A., Bekelis K., Harris B.T., Wilson B.C., Leblond F., Kim A., et al. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo. Neurosurgery 2014, 10(Suppl. 1):74-82. [discussion 82-73].
33. Valdes P.A., Kim A., Brantsch M., Niu C., Moses Z.B., Tosteson T.D., et al. Delta-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro-oncology 2011, 13:846-856.
34. Valdes P.A., Leblond F., Kim A., Harris B.T., Wilson B.C., Fan X., et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 2011, 115:11-17.
35. von Campe G., Moschopulos M., Hefti M. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir 2012, 154:585-588.
36. Whelan H.T. High-grade glioma/glioblastoma multiforme: is there a role for photodynamic therapy?. J Natl Compr Canc Netw 2012, 10(Suppl. 2):S31-S34.
37. Whittle I.R., Smith C., Navoo P., Collie D. Meningiomas. Lancet 2004, 363:1535-1543.
38. Widhalm G., Kiesel B., Woehrer A., Traub-Weidinger T., Preusser M., Marosi C., et al. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement. PLOS ONE 2013, 8:e76988.
39. Widhalm G., Minchev G., Woehrer A., Preusser M., Kiesel B., Furtner J., et al. Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev 2012, 35:381-391. [discussion 391].
40. Widhalm G., Wolfsberger S., Minchev G., Woehrer A., Krssak M., Czech T., et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 2010, 116:1545-1552.
41. Wiemels J., Wrensch M., Claus E.B. Epidemiology and etiology of meningioma. J Neuro-oncol 2010, 99:307-314.